These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15747148)

  • 1. [Bavarian mammography screening program].
    Willgeroth F; Baumann M; Blaser D; Crispin A; Froschauer S; de Waal J; Heywang-Köbrunner S; Hölzel D; Kääb V; Rothe R; Stich V; Thomaschewski S; Walter D
    Radiologe; 2005 Mar; 45(3):264-8. PubMed ID: 15747148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Introduction of a mammography screening program in Germany. Consideration of benefits and risks].
    Nekolla EA; Griebel J; Brix G
    Radiologe; 2005 Mar; 45(3):245-54. PubMed ID: 15717183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mammography screening].
    Schulz-Wendtland R; Becker N; Bock K; Anders K; Bautz W
    Radiologe; 2007 Apr; 47(4):359-69; quiz 370. PubMed ID: 17375277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of epidemiological quality parameters in a mammography screening programme].
    Becker N
    Radiologe; 2006 Nov; 46(11):984-92. PubMed ID: 16177930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of roentgen mammography for breast carcinoma screening].
    Schulz-Wendtland R; Krämer S; Döinghaus K; Säbel M; Lang N; Bautz W
    Rontgenpraxis; 1997 May; 50(5):103-9. PubMed ID: 9297252
    [No Abstract]   [Full Text] [Related]  

  • 6. Mammography and the risks of engagement.
    Pentecost MJ
    J Am Coll Radiol; 2004 Nov; 1(11):797-9. PubMed ID: 17411707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: "Mammography and the risks of engagement".
    Goldshein M
    J Am Coll Radiol; 2005 Jan; 2(1):93-4. PubMed ID: 17411771
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mammography screening in Germany].
    Diekmann S; Diekmann F
    Radiologe; 2008 Jan; 48(1):17-25. PubMed ID: 18030441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome measures of an Australian breast-screening program.
    Rodger A; Kavanagh AM
    Med J Aust; 1998 Aug; 169(4):179-80. PubMed ID: 9734571
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early results of breast cancer screening research].
    Nowicki A; Stogowska I
    Ginekol Pol; 2007 Jun; 78(6):464-70. PubMed ID: 17899703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image quality of mammography in Croatian nationwide screening program: comparison between various types of facilities.
    Brnić Z; Blašković D; Klasić B; Ramač JP; Flegarić-Bradić M; Stimac D; Lubina IZ; Brnić V; Faj D
    Eur J Radiol; 2012 Apr; 81(4):e478-85. PubMed ID: 21715115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in therapy for breast cancer patients as a result of mammography screening. An analysis of Bavarian cancer registry data from 2000 to 2008].
    Schrodi S; Braisch U; Schenkirsch G; Maisel T; Petsch S; Hölzel D; Klinkhammer-Schalke M; Mäder U; Schuller L; Heywang-Köbrunner SH; Meyer M; Engel J
    Gesundheitswesen; 2013 Oct; 75(10):632-42. PubMed ID: 23404360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality varies across clinical practice guidelines for mammography screening in women aged 40-49 years as assessed by AGREE and AMSTAR instruments.
    Burda BU; Norris SL; Holmer HK; Ogden LA; Smith ME
    J Clin Epidemiol; 2011 Sep; 64(9):968-76. PubMed ID: 21420280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
    Fuhs A; Bartholomäus S; Heidinger O; Hense HW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling of the mammographic exposure conditions for radiological detriment study in the Valencian Breast Cancer Screening Programme.
    Ferrer S; Ramos M; Villaescusa JI; Verdú G; Salas MD; Cuevas MD
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):396-400. PubMed ID: 16604667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A decentralized breast cancer screening program in the French department of Bas-Rhin].
    Schaffer P; Gairard B; Guldenfels C; Haehnel P; Dale G; Bellocq JP; Renaud R
    J Radiol; 2000 Aug; 81(8):845-57. PubMed ID: 10916002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends of process and impact indicators in Italian mammography screening programmes--1996-2004.
    Giordano L; Giorgi D; Piccini P; Ventura L; Stefanini V; Senore C; Paci E; Segnan N
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):21-32. PubMed ID: 17824360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organisational aspects of mammography screening in digital settings: first experiences of Luxembourg.
    Shannoun F; Schanck JM; Scharpantgen A; Wagnon MC; Ben Daoud M; Back C
    Radiat Prot Dosimetry; 2008; 129(1-3):195-8. PubMed ID: 18448438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.